Gregory Beatty, M.D., Ph.D.
Assistant Professor of Medicine,
Perelman School of Medicine
Attending Physician, 
University of Pennsylvania Health System

2017 Sponsors


Click here for sponsorship Information.

Contact: Stephen T. Haley, Ph.D - or (301) 606-9145 if you are interested in sponsoring the TRCCC Annual Meeting .

Copyright Translational Research Cancer Centers Consortium

Carl June, M.D.
Richard W. Vague Professor in Immunotherapy
Department: Pathology and Laboratory Medicine
Perelman School of Medicine
University of Pennsylvania 

2017 Oral & Poster Presentation Award Winners

2017 Photos

2017 Annual Meeting Chairs

Translational Research Cancer Centers Consortium

Translational Research Cancer Centers Consortium

Oral Session Name Place Title
1 Yuki Muroyama 1st Stereotactic radiotherapy increases functionally suppressive regulatory T cells in the tumor microenvironment
1 Alba Rodriguez-Garcia 2nd Selective targeting of FR‐expressing tumor associated macrophages (TAMs) improves the efficacy of CAR T‐cell therapy
2 Nicholas Minutolo 1st Redirecting gene-engineered T cells through covalent attachment of targeting ligands to a universal immune receptor
2 Yanping Lou 2nd Developing a working model for evaluating CAR-T cell therapy against mesothelin in PDA-syngeneic immune-competent mouse model
3 Kathleen Kokolus 1st Beta-adrenergic signaling blockade improves the efficacy of immunotherapy for melanoma
3 Kellie Smith 2nd The MANA functional expansion of specific T cells (MANAFEST) assay: a liquid biopsy approach for clinical monitoring of anti-tumor immune responses
4 Cameron MacDonald 1st Blockade of beta-adrenergic receptor signaling enhances anti-tumor immunity while increasing the sensitivity of tumor cells to radiation therapy
4 Mingen Liu 2nd CpG redirects macrophages to overcome inhibitory CD47 expressed by tumor cells in pancreas cancer
5 Nick Hoffend 1st Improving Dendritic Cell Vaccination: Don’t Throw the Non-Classical Monocytes Out with the Bath Water
5 Anna Wing 2nd Bispecific T-cell engager-armed oncolytic virus improves the anti-tumor effect of CAR T-cell therapy
6 Anze Smole 1st A synthetic mammalian therapeutic gene circuit for sensing and suppressing inflammation
6 Nicole Scharping 2nd Mitochondrial biogenesis is repressed in tumor-infiltrating CD8+ T cells resulting in metabolic insufficiency and T cell dysfunction
Poster Kathleen Kokolus 1st
Poster Prannda Sharma 2nd



Daniel Powell, Ph.D.
Associate Professor of Pathology and Laboratory Medicine
Ovarian Cancer Research Center
Abramson Cancer Center
Perelman School of Medicine
University of Pennsylvania






Expediting Progress in Cancer Immunotherapy